Wall Street brokerages expect HCA Holdings, Inc. (NYSE:HCA) to post earnings per share (EPS) of $1.87 for the current quarter, according to Zacks Investment Research. Ten analysts have issued estimates for HCA’s earnings. The lowest EPS estimate is $1.80 and the highest is $1.95. HCA posted earnings per share of $1.89 in the same quarter last year, which indicates a negative year over year growth rate of 1.1%. The business is expected to report its next earnings results on Tuesday, January 30th.

According to Zacks, analysts expect that HCA will report full-year earnings of $6.56 per share for the current year, with EPS estimates ranging from $6.49 to $6.64. For the next financial year, analysts expect that the company will report earnings of $7.19 per share, with EPS estimates ranging from $6.58 to $7.60. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side research analysts that cover HCA.

HCA (NYSE:HCA) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $1.21 EPS for the quarter, hitting analysts’ consensus estimates of $1.21. The company had revenue of $10.70 billion for the quarter, compared to analyst estimates of $10.70 billion. HCA had a net margin of 6.13% and a negative return on equity of 47.16%. HCA’s revenue was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.45 earnings per share.

Several research firms recently issued reports on HCA. ValuEngine upgraded shares of HCA from a “hold” rating to a “buy” rating in a report on Thursday, November 30th. Citigroup raised shares of HCA from a “neutral” rating to a “buy” rating in a research note on Tuesday. J P Morgan Chase & Co raised shares of HCA from a “neutral” rating to an “overweight” rating in a research note on Thursday, November 30th. Mizuho reaffirmed a “buy” rating on shares of HCA in a research note on Friday, October 20th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and issued a $92.00 price target on shares of HCA in a research note on Wednesday, October 4th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and nineteen have issued a buy rating to the company’s stock. HCA has an average rating of “Buy” and an average target price of $90.20.

In related news, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $79.87, for a total transaction of $171,720.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Victor L. Campbell sold 8,000 shares of the company’s stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $75.82, for a total transaction of $606,560.00. Following the sale, the senior vice president now owns 127,275 shares in the company, valued at $9,649,990.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 22,450 shares of company stock worth $1,737,681. Corporate insiders own 2.90% of the company’s stock.

Hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its position in HCA by 0.7% during the 2nd quarter. Vanguard Group Inc. now owns 19,718,250 shares of the company’s stock valued at $1,719,431,000 after buying an additional 141,258 shares during the period. Glenview Capital Management LLC boosted its position in HCA by 2.6% during the 2nd quarter. Glenview Capital Management LLC now owns 14,899,289 shares of the company’s stock valued at $1,299,218,000 after buying an additional 384,024 shares during the period. Longview Partners Guernsey LTD boosted its position in HCA by 22.6% during the 3rd quarter. Longview Partners Guernsey LTD now owns 11,135,155 shares of the company’s stock valued at $886,247,000 after buying an additional 2,053,701 shares during the period. LSV Asset Management boosted its position in HCA by 5.5% during the 2nd quarter. LSV Asset Management now owns 3,907,939 shares of the company’s stock valued at $340,772,000 after buying an additional 203,290 shares during the period. Finally, APG Asset Management N.V. boosted its position in HCA by 141.4% during the 3rd quarter. APG Asset Management N.V. now owns 3,423,381 shares of the company’s stock valued at $272,467,000 after buying an additional 2,005,193 shares during the period. Institutional investors own 75.35% of the company’s stock.

HCA (NYSE HCA) opened at $84.97 on Tuesday. The stock has a market cap of $30,037.81, a price-to-earnings ratio of 12.87, a P/E/G ratio of 1.25 and a beta of 0.56. The company has a quick ratio of 1.41, a current ratio of 1.68 and a debt-to-equity ratio of -6.46. HCA has a fifty-two week low of $71.18 and a fifty-two week high of $91.03.

TRADEMARK VIOLATION NOTICE: “HCA Holdings, Inc. (HCA) Expected to Announce Earnings of $1.87 Per Share” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.americanbankingnews.com/2017/12/12/hca-holdings-inc-hca-expected-to-announce-earnings-of-1-87-per-share.html.

About HCA

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Get a free copy of the Zacks research report on HCA (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.